ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

SBI Healthcare Opportunities Fund

SBI SBI Mutual Fund Jan 2022 — Sep 2026 57 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹5,608 CrAt NSE closes, Sep 2026
Companies held3535 with an NSE price
Top 10 holdings54.2%Of the equity shown here
Largest holding11.7%Sun Pharmaceutical Industries Limited
12-month turnover29.9%Estimated from 12 monthly disclosures · compare

Days to sell half: 14.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

57 priced months, Jan 2022 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

54.2% now, 53.2% in Sep 2025 · highest 77.3%, lowest 53.2%

Companies held

35 now, 29 in Sep 2025 · largest single holding 11.7% of equity

How long new positions last: of the 20 companies this fund started holding between Nov 2022 and Aug 2025, 75% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →

How it trades: leans toward adding to shares that fell over the previous six months (score -0.16 over 24 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 26 shared64.1%
  2. WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 27 shared62.1%
  3. Bandhan BSE Healthcare Index FundBandhan · 33 shared61.8%
  4. Motilal Oswal BSE Healthcare ETFMotilal Oswal · 33 shared61.8%
  5. Mirae Asset Healthcare FundMirae Asset · 17 shared59.9%
  6. EODWHFEdelweiss · 16 shared58.9%
  7. Axis NIFTY Healthcare ETFAxis · 14 shared56.2%
  8. ICICI Prudential Nifty Healthcare ETFICICI Prudential · 14 shared56.2%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 3 Companies added
Complete exits 0 Companies sold out
Increases 2 More shares than last month
Reductions 4 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 11.66% 654 Cr 0.36 Cr by Jan 2022 (57 mo+)
Divi's Laboratories Limited Healthcare Large Cap 8.28% 465 Cr 0.05 Cr by Jan 2022 (57 mo+)
Acutaas Chemicals Limited Healthcare Small Cap 5.26% 295 Cr 0.09 Cr Jun 2024 (28 mo)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 4.66% 261 Cr 0.03 Cr Jan 2026 (9 mo)
Torrent Pharmaceuticals Limited Healthcare Large Cap 4.62% 259 Cr 0.05 Cr by Jan 2022 (57 mo+)
Cipla Limited Healthcare Large Cap 4.61% 258 Cr 0.19 Cr May 2026 (5 mo)
Laurus Labs Limited Healthcare Mid Cap 4.24% 238 Cr 0.12 Cr Aug 2023 (38 mo)
Max Healthcare Institute Limited Healthcare Large Cap 3.98% 223 Cr 0.24 Cr by Jan 2022 (57 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 3.58% 201 Cr 0.12 Cr Mar 2026 (7 mo)
Aster DM Quality Care Limited Healthcare Small Cap 3.36% 188 Cr 0.27 Cr Mar 2024 (31 mo)
Gland Pharma Limited Healthcare Small Cap 3.10% 174 Cr 0.06 Cr by Jan 2022 (57 mo+)
Sudeep Pharma Limited Chemicals Small Cap 2.92% 164 Cr 0.14 Cr Nov 2025 (11 mo)
Anthem Biosciences Limited Healthcare Mid Cap 2.88% 161 Cr 0.19 Cr Jul 2025 (15 mo)
Sai Life Sciences Limited Healthcare Small Cap 2.72% 152 Cr 0.10 Cr Jan 2026 (9 mo)
CORONA Remedies Limited Not classified Small Cap 2.54% 142 Cr 0.07 Cr Sep 2026 (1 mo)
Biocon Limited Healthcare Mid Cap 2.48% 139 Cr 0.38 Cr Nov 2024 (23 mo)
Fortis Healthcare Limited Healthcare Mid Cap 2.47% 139 Cr 0.18 Cr by Jan 2022 (57 mo+)
Concord Biotech Limited Healthcare Small Cap 2.35% 132 Cr 0.10 Cr Nov 2024 (23 mo)
Aether Industries Limited Chemicals Small Cap 2.27% 127 Cr 0.07 Cr May 2022 (53 mo)
Jupiter Life Line Hospitals Limited Not classified Small Cap 2.26% 127 Cr 0.50 Cr Aug 2023 (38 mo)
Poly Medicure Limited Healthcare Small Cap 1.91% 107 Cr 0.06 Cr Aug 2024 (26 mo)
Ajanta Pharma Limited Healthcare Small Cap 1.87% 105 Cr 0.03 Cr Feb 2026 (8 mo)
Global Health Limited Healthcare Mid Cap 1.83% 102 Cr 0.07 Cr May 2026 (5 mo)
Mankind Pharma Limited Healthcare Mid Cap 1.79% 100 Cr 0.04 Cr Apr 2023 (42 mo)
Healthcare Global Enterprises Limited Healthcare Small Cap 1.78% 99.91 Cr 0.15 Cr Jul 2026 (3 mo)
Krishna Institute of Medical Sciences Limited Healthcare Small Cap 1.77% 99.36 Cr 0.13 Cr Nov 2022 (47 mo)
Cohance Lifesciences Limited Healthcare Small Cap 1.74% 97.68 Cr 0.22 Cr Jun 2024 (28 mo)
Innova Captab Limited Not classified Small Cap 1.72% 96.64 Cr 0.08 Cr Sep 2026 (1 mo)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 1.70% 95.38 Cr 0.05 Cr May 2026 (5 mo)
Nephrocare Health Services Limited Healthcare Small Cap 1.18% 65.97 Cr 0.10 Cr Dec 2025 (10 mo)
Syngene International Limited Healthcare Small Cap 1.17% 65.75 Cr 0.18 Cr Jul 2026 (3 mo)
Rainbow Childrens Medicare Limited Healthcare Small Cap 0.70% 39.43 Cr 0.03 Cr Mar 2026 (7 mo)
Gufic Biosciences Limited Not classified Small Cap 0.31% 17.28 Cr 0.04 Cr by Jan 2022 (57 mo+)
Abbott India Limited Healthcare Mid Cap 0.24% 13.56 Cr 5,000 by Jan 2022 (57 mo+)
Novartis India Limited Not classified Small Cap 0.04% 2.34 Cr 12,179 Sep 2026 (1 mo)

Half of its current holdings have been held for 23 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Innova Captab Limited Sep 2026 ▲ New position +0.08 Cr
CORONA Remedies Limited Sep 2026 ▲ New position +0.07 Cr
Healthcare Global Enterprises Limited Sep 2026 ▲ Increasing +0.05 Cr
Aurobindo Pharma Limited Sep 2026 ▼ Reducing -0.01 Cr
Aether Industries Limited Sep 2026 ▼ Reducing -49,674
Dr. Lal Path Labs Ltd. Sep 2026 ▲ Increasing +40,000
Novartis India Limited Sep 2026 ▲ New position +12,179
Ajanta Pharma Limited Sep 2026 ▼ Reducing -9,591
Abbott India Limited Sep 2026 ▼ Reducing -2,764
Syngene International Limited Aug 2026 ▲ Increasing +0.05 Cr
Healthcare Global Enterprises Limited Aug 2026 ▲ Increasing +0.04 Cr
Lupin Limited Aug 2026 ▼ Complete exit -0.04 Cr
Jupiter Life Line Hospitals Limited Aug 2026 ▲ Increasing +0.03 Cr
Fortis Healthcare Limited Aug 2026 ▲ Increasing +0.03 Cr
Aster DM Quality Care Limited Aug 2026 ▲ Increasing +0.03 Cr
Concord Biotech Limited Aug 2026 ▲ Increasing +0.02 Cr
Max Healthcare Institute Limited Aug 2026 ▲ Increasing +0.01 Cr
Sun Pharmaceutical Industries Limited Aug 2026 ▲ Increasing +0.01 Cr
Dr. Lal Path Labs Ltd. Aug 2026 ▲ Increasing +0.01 Cr
Global Health Limited Aug 2026 ▲ Increasing +0.01 Cr
Gufic Biosciences Limited Aug 2026 ▼ Reducing -0.01 Cr
Cipla Limited Aug 2026 ▲ Increasing +60,000
Nephrocare Health Services Limited Aug 2026 ▲ Increasing +47,101
Torrent Pharmaceuticals Limited Aug 2026 ▲ Increasing +40,000
Apollo Hospitals Enterprise Limited Aug 2026 ▲ Increasing +20,000
Abbott India Limited Aug 2026 ▼ Reducing -12,236
Aurobindo Pharma Limited Aug 2026 ▼ Reducing -1,808
Ajanta Pharma Limited Aug 2026 ▼ Reducing -618
Aether Industries Limited Aug 2026 ▼ Reducing -326
Syngene International Limited Jul 2026 ▲ New position +0.13 Cr
Cipla Limited Jul 2026 ▲ Increasing +0.07 Cr
Healthcare Global Enterprises Limited Jul 2026 ▲ New position +0.06 Cr
Sun Pharmaceutical Industries Limited Jul 2026 ▲ Increasing +0.04 Cr
Aether Industries Limited Jul 2026 ▼ Reducing -0.02 Cr
Jupiter Life Line Hospitals Limited Jul 2026 ▲ Increasing +0.02 Cr
Mankind Pharma Limited Jul 2026 ▼ Reducing -0.02 Cr
Nephrocare Health Services Limited Jul 2026 ▲ Increasing +0.02 Cr
Torrent Pharmaceuticals Limited Jul 2026 ▲ Increasing +0.01 Cr
Global Health Limited Jul 2026 ▲ Increasing +80,000
Divi's Laboratories Limited Jul 2026 ▲ Increasing +50,000
Anthem Biosciences Limited Jul 2026 ▲ Increasing +40,000
Abbott India Limited Jul 2026 ▼ Reducing -4,000
Cipla Limited Jun 2026 ▲ Increasing +0.06 Cr
Cohance Lifesciences Limited Jun 2026 ▲ Increasing +0.04 Cr
Sun Pharmaceutical Industries Limited Jun 2026 ▲ Increasing +0.02 Cr
Alkem Laboratories Limited Jun 2026 ▼ Complete exit -0.02 Cr
Krishna Institute of Medical Sciences Limited Jun 2026 ▲ Increasing +0.01 Cr
Aether Industries Limited Jun 2026 ▼ Reducing -0.01 Cr
Aurobindo Pharma Limited Jun 2026 ▲ Increasing +70,000
Dr. Lal Path Labs Ltd. Jun 2026 ▲ Increasing +60,000
Anthem Biosciences Limited Jun 2026 ▲ Increasing +37,793
Abbott India Limited Jun 2026 ▼ Reducing -1,000
Cohance Lifesciences Limited May 2026 ▲ Increasing +0.08 Cr
Cipla Limited May 2026 ▲ New position +0.06 Cr
Global Health Limited May 2026 ▲ New position +0.06 Cr
Krishna Institute of Medical Sciences Limited May 2026 ▼ Reducing -0.04 Cr
Lupin Limited May 2026 ▼ Reducing -0.03 Cr
Aurobindo Pharma Limited May 2026 ▲ Increasing +0.03 Cr
Dr. Lal Path Labs Ltd. May 2026 ▲ New position +0.02 Cr
Gufic Biosciences Limited May 2026 ▼ Reducing -0.02 Cr
Anthem Biosciences Limited May 2026 ▼ Reducing -0.02 Cr
Medplus Health Services Limited May 2026 ▼ Complete exit -0.01 Cr
Aether Industries Limited May 2026 ▼ Reducing -0.01 Cr
Mankind Pharma Limited May 2026 ▼ Reducing -80,000
Sanofi Consumer Healthcare India Limited May 2026 ▼ Complete exit -40,000
Alkem Laboratories Limited May 2026 ▼ Reducing -25,000
Vijaya Diagnostic Centre Limited Apr 2026 ▼ Complete exit -0.03 Cr
Cohance Lifesciences Limited Apr 2026 ▼ Reducing -0.02 Cr
Aurobindo Pharma Limited Apr 2026 ▲ Increasing +0.02 Cr
Rainbow Childrens Medicare Limited Apr 2026 ▲ Increasing +0.02 Cr
Max Healthcare Institute Limited Apr 2026 ▲ Increasing +0.01 Cr
Gufic Biosciences Limited Apr 2026 ▼ Reducing -95,259
Aether Industries Limited Apr 2026 ▼ Reducing -84,798
CORONA Remedies Limited Apr 2026 ▼ Complete exit -75,000
Sai Life Sciences Limited Apr 2026 ▲ Increasing +64,595
Medplus Health Services Limited Apr 2026 ▼ Reducing -50,000
Sanofi Consumer Healthcare India Limited Apr 2026 ▼ Reducing -20,000
Abbott India Limited Apr 2026 ▼ Reducing -5,000
Anthem Biosciences Limited Apr 2026 ▲ Increasing +508
Aurobindo Pharma Limited Mar 2026 ▲ New position +0.08 Cr
Anthem Biosciences Limited Mar 2026 ▲ Increasing +0.04 Cr
Sun Pharmaceutical Industries Limited Mar 2026 ▲ Increasing +0.03 Cr
Max Healthcare Institute Limited Mar 2026 ▲ Increasing +0.03 Cr
Gufic Biosciences Limited Mar 2026 ▼ Reducing -0.02 Cr
Sai Life Sciences Limited Mar 2026 ▲ Increasing +0.01 Cr
Rainbow Childrens Medicare Limited Mar 2026 ▲ New position +0.01 Cr
Laurus Labs Limited Mar 2026 ▼ Reducing -0.01 Cr
Mankind Pharma Limited Mar 2026 ▲ Increasing +0.01 Cr
Medplus Health Services Limited Mar 2026 ▼ Reducing -0.01 Cr
Fortis Healthcare Limited Mar 2026 ▲ Increasing +0.01 Cr
Aether Industries Limited Mar 2026 ▼ Reducing -80,000
Ajanta Pharma Limited Mar 2026 ▲ Increasing +50,000
Torrent Pharmaceuticals Limited Mar 2026 ▼ Reducing -40,000
Lupin Limited Mar 2026 ▼ Reducing -30,000
Divi's Laboratories Limited Mar 2026 ▼ Reducing -30,000
Pfizer Limited Mar 2026 ▼ Complete exit -30,000
CORONA Remedies Limited Mar 2026 ▼ Reducing -25,000
Sanofi Consumer Healthcare India Limited Mar 2026 ▼ Reducing -15,000
Aurobindo Pharma Limited Feb 2026 ▼ Complete exit -0.07 Cr
Ajanta Pharma Limited Feb 2026 ▲ New position +0.03 Cr

Changes compare consecutive month-end disclosures for this portfolio only.